Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Optimizerx Corporation (OPRX:NASDAQ), powered by AI.
Optimizerx Corporation is currently trading at $5.28. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Optimizerx Corporation on Alpha Lenz.
Optimizerx Corporation's P/E ratio is 19.1.
“Optimizerx Corporation trades at a P/E of 19.1 (fair value) with modest ROE of 4.2%. 3Y revenue CAGR of 20.6% highlights clear growth momentum.”
Ask for details →Optimizerx Corporation is a digital health platform provider focused on enhancing communication between life science organizations, healthcare providers, and patients. Its primary function is to deliver seamless integration of financial assistance, patient support, and clinical information into healthcare systems. By operating within the healthcare technology sector, Optimizerx plays a pivotal role in enabling industry stakeholders to improve patient care outcomes, optimize the use of medications, and ultimately streamline the process of healthcare delivery. The company's innovative solutions facilitate the swift exchange of information, making healthcare more accessible and affordable for patients. In the broader financial market, Optimizerx Corporation represents the intersection of technology and healthcare, highlighting the growing trend towards digital solutions in enhancing healthcare delivery and patient engagement. As a publicly traded entity, it offers insights into the economic dynamics of the digital health space and its potential impact on the industry as a whole.
“Optimizerx Corporation trades at a P/E of 19.1 (fair value) with modest ROE of 4.2%. 3Y revenue CAGR of 20.6% highlights clear growth momentum.”
Ask for details →Optimizerx Corporation (ticker: OPRX) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 128 employees. Market cap is $98M.
The current price is $5.28 with a P/E ratio of 19.09x and P/B of 0.76x.
ROE is 4.18% and operating margin is 11.02%. Annual revenue is $109M.